Skip to main content

Hormonal, Reproductive Factors Linked to RA Risk Among Women

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 10, 2024 -- Certain hormonal and reproductive factors are associated with an increased risk for rheumatoid arthritis (RA) among women, according to a study published online Jan. 9 in RMD Open.

Ling-Qiong Jiang, from the Anhui Medical University School of Public Health in Hefei, China, and colleagues collected data on hormonal and reproductive factors in women from a prospective cohort of 223,526 U.K. Biobank participants to examine the association with RA risk.

The researchers identified 3,313 women with RA during a median follow-up of 12.39 years. Compared with menarche at 13 years, menarche at >14 years was associated with increased RA risk (hazard ratio [HR], 1.13). For women with menopause at younger than 45 years, the multiple adjusted HR for RA was 1.46. The risk for RA was increased with reproductive years <33 (HR, 1.39). Women with at least four versus two children had a higher risk for RA (HR, 1.18). The risk for RA was higher among those with a hysterectomy or oophorectomy versus those without (HRs, 1.40 and 1.21, respectively). Hormone replacement therapy use and duration were both associated with an increased risk for RA (HRs, 1.46 and 1.02, respectively).

"The findings of this study are significant and form a basis on which novel and target-specific intervention measures to curb the risk of RA in women may be developed," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.